12th Edition of International Conference on Neurology and Brain Disorders
October 20-22, 2025
Neurogenetics
The field of neurogenetics is dedicated to understanding the role of genetics in the development and progression of neurological disorders. Researchers are uncovering how mutations in specific genes lead to a wide range of conditions, from rare inherited diseases to more common neurological disorders like multiple sclerosis and Parkinson’s disease. The use of advanced technologies, such as genome-wide association studies (GWAS), is helping to identify new genetic variants associated with neurological diseases, offering insights into their underlying causes. Furthermore, the advent of gene therapy and genome editing techniques is providing new hope for treating genetic neurological conditions by correcting or replacing faulty genes. The study of epigenetics also plays a vital role in understanding how environmental factors influence genetic expression in the brain.
Ken Ware
NeuroPhysics Therapy Institute and Research Centre, Australia
Joe Sam Robinson
Mercer University, United States
Robert B Slocum
University of Kentucky HealthCare, United States
Thomas J Webster
Interstellar Therapeutics, United States
Roger H Coletti
Interventional Health, PA, United States
Stephen Grossberg
Boston University, United States
George Diaz
Memorial Healthcare Systems, United StatesSubmit your abstract Today
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : TBI updates in 2025
Jonathan Eskenazi, Cedars Sinai / UCLA, United States
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Non-pharmacological strategies to counteract oxaliplatin toxicity: Protective effects of vagal nerve stimulation and resistance training on neuropathy, motor dysfunction, and muscle atrophy
Ricardo Aparecido Baptista Nucci, Hospital Sirio-Libanes, Brazil
Title : Synapticare: Integrating sleep data and tau biomarkers to assess depression severity
Medha Menon, John Foster Dulles HS, United States
Title : How have we eliminated infection: From the bone to brain?
Thomas J Webster, Interstellar Therapeutics, United States